Table of Contents

2019-2024 Global Scopolamine Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Scopolamine Consumption 2014-2024
  • 2.1.2 Scopolamine Consumption CAGR by Region
• 2.2 Scopolamine Segment by Type
  • 2.2.1 Scopolamine Butylbromide
  • 2.2.2 Scopolamine Hydrobromide
  • 2.2.3 Scopolamine Base
• 2.3 Scopolamine Consumption by Type
  • 2.3.1 Global Scopolamine Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Scopolamine Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Scopolamine Sale Price by Type (2014-2019)
• 2.4 Scopolamine Segment by Application
  • 2.4.1 Oral
  • 2.4.2 Injection
  • 2.4.3 Patches
• 2.5 Scopolamine Consumption by Application
  • 2.5.1 Global Scopolamine Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Scopolamine Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Scopolamine Sale Price by Application (2014-2019)

3 Global Scopolamine by Players

• 3.1 Global Scopolamine Sales Market Share by Players
  • 3.1.1 Global Scopolamine Sales by Players (2017-2019)
  • 3.1.2 Global Scopolamine Sales Market Share by Players (2017-2019)
• 3.2 Global Scopolamine Revenue Market Share by Players
  • 3.2.1 Global Scopolamine Revenue by Players (2017-2019)
  • 3.2.2 Global Scopolamine Revenue Market Share by Players (2017-2019)
• 3.3 Global Scopolamine Sale Price by Players
• 3.4 Global Scopolamine Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Scopolamine Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Scopolamine Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Scopolamine by Regions

• 4.1 Scopolamine by Regions
  • 4.1.1 Global Scopolamine Consumption by Regions
  • 4.1.2 Global Scopolamine Value by Regions
• 4.2 Americas Scopolamine Consumption Growth
• 4.3 APAC Scopolamine Consumption Growth
• 4.4 Europe Scopolamine Consumption Growth
• 4.5 Middle East & Africa Scopolamine Consumption Growth

5 Americas

• 5.1 Americas Scopolamine Consumption by Countries
  • 5.1.1 Americas Scopolamine Consumption by Countries (2014-2019)
  • 5.1.2 Americas Scopolamine Value by Countries (2014-2019)
• 5.2 Americas Scopolamine Consumption by Type
• 5.3 Americas Scopolamine Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Scopolamine Consumption by Countries
  • 6.1.1 APAC Scopolamine Consumption by Countries (2014-2019)
  • 6.1.2 APAC Scopolamine Value by Countries (2014-2019)
• 6.2 APAC Scopolamine Consumption by Type
• 6.3 APAC Scopolamine Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Scopolamine by Countries
  • 7.1.1 Europe Scopolamine Consumption by Countries (2014-2019)
  • 7.1.2 Europe Scopolamine Value by Countries (2014-2019)
• 7.2 Europe Scopolamine Consumption by Type
• 7.3 Europe Scopolamine Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Scopolamine by Countries
  • 8.1.1 Middle East & Africa Scopolamine Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Scopolamine Value by Countries (2014-2019)
• 8.2 Middle East & Africa Scopolamine Consumption by Type
• 8.3 Middle East & Africa Scopolamine Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Scopolamine Distributors
• 10.3 Scopolamine Customer

11 Global Scopolamine Market Forecast

• 11.1 Global Scopolamine Consumption Forecast (2019-2024)
• 11.2 Global Scopolamine Forecast by Regions
  • 11.2.1 Global Scopolamine Forecast by Regions (2019-2024)
  • 11.2.2 Global Scopolamine Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Scopolamine Forecast by Type
• 11.8 Global Scopolamine Forecast by Application

12 Key Players Analysis

• 12.1 Alkaloids of Australia
  • 12.1.1 Company Details
  • 12.1.2 Scopolamine Product Offered
  • 12.1.3 Alkaloids of Australia Scopolamine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Alkaloids of Australia News
• 12.2 Centroflora-cms
  • 12.2.1 Company Details
  • 12.2.2 Scopolamine Product Offered
  • 12.2.3 Centroflora-cms Scopolamine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Centroflora-cms News
• 12.3 Fine Chemicals Corporation
  • 12.3.1 Company Details
  • 12.3.2 Scopolamine Product Offered
  • 12.3.3 Fine Chemicals Corporation Scopolamine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Fine Chemicals Corporation News
• 12.4 Phytex Australia
  • 12.4.1 Company Details
  • 12.4.2 Scopolamine Product Offered
  • 12.4.3 Phytex Australia Scopolamine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Phytex Australia News
• 12.5 Alchem International
  • 12.5.1 Company Details
  • 12.5.2 Scopolamine Product Offered
  • 12.5.3 Alchem International Scopolamine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Alchem International News
• 12.6 Guangzhou Hanfang
  • 12.6.1 Company Details
  • 12.6.2 Scopolamine Product Offered
  • 12.6.3 Guangzhou Hanfang Scopolamine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Guangzhou Hanfang News
• 12.7 Alkaloids Corporation
  • 12.7.1 Company Details
  • 12.7.2 Scopolamine Product Offered
  • 12.7.3 Alkaloids Corporation Scopolamine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Alkaloids Corporation News
• 12.8 Luyin
  • 12.8.1 Company Details
  • 12.8.2 Scopolamine Product Offered
  • 12.8.3 Luyin Scopolamine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Luyin News

13 Research Findings and Conclusion

Scopolamine is a medication used in the treatment of motion sickness and postoperative nausea and vomiting. Scopolamine is used to prevent nausea and vomiting caused by motion sickness or from anesthesia given during surgery.
The global production of scopolamine about 2450 Kg in 2015, the production region is mainly concentrated in Australia witch product 43.63% of global scopolamine. The top three companies are Alkaloids of Australia, Centroflora-cms and Fine Chemicals Corporation, they occupies about 62.37% market shares.
Although the production region is very concentration, the consumption region is very dispersion, in 2015, the largest consumption North America is about 30.68%, the Europe consumes about 26.65% market share, China occupies about 9.88% market share, Japan occupies about 10.78% market share.

According to this study, over the next five years the Scopolamine market will register a 3.8% CAGR in terms of revenue, the global market size will reach US$ 20 million by 2024, from US$ 16 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Scopolamine business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Scopolamine market by product type, application, key manufacturers and key regions and countries.

This study considers the Scopolamine value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Scopolamine Butylbromide
Scopolamine Hydrobromide
Scopolamine Base
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Oral
Injection
Patches

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Alkaloids of Australia
Centroflora-cms
Fine Chemicals Corporation
Phytex Australia
Alchem International
Guangzhou Hanfang
Alkaloids Corporation
Luyin

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Scopolamine consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Scopolamine market by identifying its various subsegments.
Focuses on the key global Scopolamine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Scopolamine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Scopolamine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.